These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18188500)

  • 21. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli.
    Soto SM; Smithson A; Horcajada JP; Martinez JA; Mensa JP; Vila J
    Clin Microbiol Infect; 2006 Oct; 12(10):1034-6. PubMed ID: 16961644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains.
    Markusková B; Elnwrani S; Andrezál M; Sedláčková T; Szemes T; Slobodníková L; Kajsik M; Drahovská H
    Arch Virol; 2024 Jun; 169(7):142. PubMed ID: 38851653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic
    Slobodníková L; Markusková B; Kajsík M; Andrezál M; Straka M; Liptáková A; Drahovská H
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophage therapy for
    Bhargava K; Nath G; Dhameja N; Kumar R; Aseri GK; Jain N
    Future Microbiol; 2023 Apr; 18():323-334. PubMed ID: 37140267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and characterisation of new phage targeting uropathogenic Escherichia coli.
    Asgharzadeh Kangachar S; Logel DY; Trofimova E; Zhu HX; Zaugg J; Schembri MA; Weynberg KD; Jaschke PR
    Virology; 2024 Sep; 597():110148. PubMed ID: 38941748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.
    Galtier M; De Sordi L; Maura D; Arachchi H; Volant S; Dillies MA; Debarbieux L
    Environ Microbiol; 2016 Jul; 18(7):2237-45. PubMed ID: 26971586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae.
    Bidhendi SM; Sattari M; Pourbakhsh SA; Mobarez A; Vandyousefi J; Khaki P; Heidari MH; Kazemnejad A
    Biologicals; 2007 Apr; 35(2):99-105. PubMed ID: 16879977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage vB_Ec_ZCEC14 to treat antibiotic-resistant Escherichia coli isolated from urinary tract infections.
    Ismael NM; Azzam M; Abdelmoteleb M; El-Shibiny A
    Virol J; 2024 Feb; 21(1):44. PubMed ID: 38365702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Escherichia coli uropathogenic genes (kps, usp and ireA) and enteroaggregative genes (aggR and aap) via multiplex polymerase chain reaction from suprapubic urine specimens of young children with fever.
    Park HK; Jung YJ; Chae HC; Shin YJ; Woo SY; Park HS; Lee SJ
    Scand J Urol Nephrol; 2009; 43(1):51-7. PubMed ID: 18759167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing urinary tract infections through phage therapy: a novel approach.
    Malik S; Sidhu PK; Rana JS; Nehra K
    Folia Microbiol (Praha); 2020 Apr; 65(2):217-231. PubMed ID: 31494814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aryloxoalcanoic compounds induce resistance to antibiotic therapy in urinary tract infection caused by Escherichia coli.
    Balagué C; Stürtz N; Rey R; De Ruiz CS; Nader-Macías ME; Duffard R; De Duffard AM
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):337-46. PubMed ID: 17034416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inheritance of susceptibility to induced Escherichia coli bladder and kidney infections in female C3H/HeJ mice.
    Hopkins WJ; Elkahwaji JE; Heisey DM; Ott CJ
    J Infect Dis; 2003 Feb; 187(3):418-23. PubMed ID: 12552425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phage typing of rough E. coli strains isolated from urine (author's transl)].
    Budde E; Nimmich W; Naumann G
    Zentralbl Bakteriol Orig A; 1978 Dec; 242(4):462-7. PubMed ID: 373321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
    Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG
    Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity.
    Mahichi F; Synnott AJ; Yamamichi K; Osada T; Tanji Y
    FEMS Microbiol Lett; 2009 Jun; 295(2):211-7. PubMed ID: 19453513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgA response of BALB/c mice to orally administered Salmonella typhimurium flagellin-displaying T2 bacteriophages.
    Synnott A; Ohshima K; Nakai Y; Tanji Y
    Biotechnol Prog; 2009; 25(2):552-8. PubMed ID: 19334277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.
    Vinodkumar CS; Neelagund YF; Kalsurmath S
    J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of antibiotic resistance and phylogenetic group patterns in human and porcine urinary tract infectious Escherichia coli.
    Hancock V; Nielsen EM; Krag L; Engberg J; Klemm P
    APMIS; 2009 Nov; 117(11):786-90. PubMed ID: 19845528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.